Facebook LinkedIn Twitter Tessie Sanci U.S. corporate profits rising for the first time since pandemic began Canadian banks, bellwethers of pandemic recovery, to reveal key statistics this week One year after price collapse, expectations are high for oil company earnings Although equity performance has been fairly lackluster lately, investors should not desert equity markets as they are still expected to outperform bond markets in 2016, according to a report by Toronto-based CIBC World Markets Inc. released on Thursday. “Our top-down earnings model, which looks at indicators like economic growth and resources prices, points to 10% growth in earnings for the [Toronto Stock Exchange] in the next four quarters,” says Avery Shenfeld, chief economist with Canadian Imperial Bank of Commerce (CIBC) and co-author of the report, in a statement. “While slow economic growth may indicate middling equity market performance, now is not the time to sell given that alternative cash and bond yields are so abysmally low.” Keywords Earnings Share this article and your comments with peers on social media Related news The analysis finds Canadian and U.S. equity markets are expected to deliver modest but positive real returns thanks to a slight improvement in commodities prices, marginally better overall gross domestic product growth and the benefits of a weaker Canadian dollar on foreign earnings. The CIBC World Markets report acknowledges that its estimate for 10% growth in the Canadian financial market trails the more optimistic views of other analysts who have cited growth of 20%-30% in 2016. “The analyst consensus is simply capturing an out-of-date set of estimates for energy sector earnings that are still in the process of a reality check downgrade,” the report argues. There is also some hope for Canadian non-resources stocks, according to Shenfeld: “On a forward [price/earnings] basis, Canadian non-resources stocks are now at historically cheap levels relative to comparable stocks on the S&P 500, which suggests these could outperform those in the U.S. in coming quarters.” In looking at U.S. equities, the report states that a cyclical adjusted price/earnings ratio is consistent with an annual nominal return of approximately 5% in the decade ahead. CIBC World Market’s research anticipates an annual real price return of 1%, which will be assisted by a dividend yield of approximately 2% and average inflation of 2%. “[It’s] nothing to really cheer about, but not a huge reason to sell given that alternative cash and bond yields are so abysmally low,” the report states.
Menopause to become the next game-changer in global femtech solutions industry by 2025 Arreka Jorkman 1 year Related Posts In a first, a ‘digital twin’ of the human cardiovascular system will be developed by researchers at the University of Sheffield. The project aims to transform how doctors diagnose and treat cardiovascular disease, giving patients real-time support to monitor their health alongside care from their doctor.The ‘Enhancing Cardiac Care Through Extensive Sensing’ (ECHOES) project will bring together international academic and industrial partners, to develop accessible wearable technology that can be used to capture the experiences, symptoms and cardiovascular data of an individual during their daily life.The University of Sheffield is a major partner in a research consortium of experts in cardiovascular medicine, science, engineering and computer science, that will develop this next generation health technology.Artificial intelligence and machine learning techniques will analyse the data alongside genetic and healthcare data, creating a digital twin of a patient’s heart to transform the diagnosis, monitoring and treatment of heart and circulatory diseases; leading to better patient outcomes and more effective treatment.ECHOES was announced today as one of the four shortlisted international research projects competing for a single £30 million funding award from the British Heart Foundation’s Big Beat Challenge: a global initiative to galvanise researchers and inspire the development of transformational solutions to tackle the world’s biggest killer.ECHOES was chosen as a finalist due to its ‘radical’ approach to cardiovascular research and the clear benefit it could bring to patients.Professor Tim Chico from the University of Sheffield is the UK co-ordinator of the ECHOES consortium. He said, “Cardiovascular disease (CVD) often suffers from low rates of first time diagnosis, resulting in repeated hospital tests, appointments and delays to getting patients on the right treatment pathway.“A digital twin that works in real-time alongside a patient – changing and aging with them – will provide a wealth of valuable information to assist doctors in diagnosing heart disease as early as possible.“It may also be able to identify changes that haven’t yet caused any symptoms or signs, providing vital clinical information that can sometimes be missing from a patient’s medical history.“Using pioneering technology and techniques, we can view the cardiovascular system much like an engineer would a manufacturing system, to analyse and manage the conditions that will allow it to function at optimum levels for the patient for as long as possible.”Professor Nilesh Samani, Medical Director at the British Heart Foundation, said, “The Big Beat Challenge embodies our ambition to turbo-charge progress and could lead to its own ‘man on the moon’ moment for heart and circulatory diseases, which remain the number one cause of death worldwide.“This is high-risk, high-reward research. We whole-heartedly believe in the transformational potential of the Big Beat Challenge to save and improve lives, both here in the UK and around the world. It represents the single biggest investment in pioneering science in the BHF’s 60-year history. In an ideal world, we’d like to fund all four as each one has the chance to make a monumental impact.”Professor of Translational Cardiopulmonary Science from the University of Sheffield, Allan Lawrie, will also be working with the ECHOES team. He added, “In Sheffield, we have a long history of innovation within cardiac research, contributing to many breakthroughs and ‘firsts’ in treatment for a number of different cardiac conditions.“ECHOES and the Big Beat Challenge is a once in a lifetime opportunity to collaborate with our international partners to keep people healthier for longer, and effectively treat what remains one of the world’s leading causes of death.” Comments (1) Read Article Sheffield team to create a ‘digital twin’ of human heart A research consortium will use the latest in sensing technologies and machine learning to provide real-time insights and transform how doctors identify those at high-risk of heart disease, and how current patients are treated Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Phoenix Business Consulting invests in telehealth platform Healpha After my Coronary Artery Disease (CAD) diagnoses, I was immediately advised for a coronary angioplasty, then a stent. After a while my condition got worse again with severe shortness of breath and angina, so i started on a natural CORONARY ARTERY DISEASE (CAD) TREATMENT from Herbal Health Point, the herbal treatment was very effective treating my heart condition and the shortness of breath. I had a total decline in symptoms. Visit their web page ww w. herbalhealthpoint. c om. Its been 2 years since the treatment, I do lots of walking and lost some weight. My daughter also used their CHF product for her congestive heart failure, very effective. News Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care app Share WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” By EH News Bureau on January 27, 2020 Add Comment digital twinECHOESEnhancing Cardiac Care Through Extensive Sensing’human heartUniversity of Sheffield The missing informal workers in India’s vaccine story